Pharma Mar
(OTC) PHMMF
Pharma Mar Financials at a Glance
Market Cap
$1.85B
Revenue (TTM)
$221.42M
Net Income (TTM)
$75.06M
EPS (TTM)
$4.97
P/E Ratio
21.38
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$106.48
Volume
10,350
Open
$106.15
Price
$106.48
Volume
10,350
Open
$106.15
Previous Close
$106.48
Daily Range
$106.15 - $106.48
52-Week Range
$80.91 - $110.40
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$106.48
Volume
10,350
Open
$106.15
Previous Close
$106.48
Daily Range
$106.15 - $106.48
52-Week Range
$80.91 - $110.40
PHMMF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Pharma Mar
Industry
Biotechnology
Sector
Health CareCEO
José Maria Fernández de Sousa-Faro, PhD, MBA
Website
www.pharmamar.comHeadquarters
Madrid, 28770, ES
PHMMF Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
25%
Net Income Margin
34%
Return on Equity
34%
Return on Capital
18%
Return on Assets
19%
Earnings Yield
4.68%
Dividend Yield
0.00%
Payout Ratio
18.60%
Stock Overview
Market Cap
$1.85B
Shares Outstanding
17.36M
Volume
10.35K
Short Interest
0.00%
Avg. Volume
421.967
Financials (TTM)
Gross Profit
$209.05M
Operating Income
$40.26M
EBITDA
$48.28M
Operating Cash Flow
$53.11M
Capital Expenditure
$9.38M
Free Cash Flow
$43.73M
Cash & ST Invst.
$167.16M
Total Debt
$50.53M
Pharma Mar Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$90.44M
+87.0%
Gross Profit
$84.64M
+79.9%
Gross Margin
93.59%
N/A
Market Cap
$1.85B
N/A
Market Cap/Employee
$3.70M
N/A
Employees
500
N/A
Net Income
$59.64M
+219.2%
EBITDA
$42.30M
+178.2%
Quarterly Fundamentals
Net Cash
$116.63M
+12.7%
Accounts Receivable
$60.57M
+74.7%
Inventory
$54.08M
+6.3%
Long Term Debt
$37.80M
-8.3%
Short Term Debt
$12.73M
+29.2%
Return on Assets
18.98%
N/A
Return on Invested Capital
18.32%
N/A
Free Cash Flow
$27.31M
+13357.2%
Operating Cash Flow
$33.57M
+1885.2%